跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Diversity of and initiatives for hypertension management in Asia—Why we need the HOPE Asia Network
Kazuomi Kario
*
, Yook Chin Chia
, Apichard Sukonthasarn
, Yuda Turana
, Jinho Shin
,
Chen Huan Chen
, Peera Buranakitjaroen
, Jennifer Nailes
, Satoshi Hoshide
, Saulat Siddique
, Jorge Sison
, Arieska Ann Soenarta
, Guru Prasad Sogunuru
, Jam Chin Tay
, Boon Wee Teo
, Yu Qing Zhang
, Sungha Park
, Huynh Van Minh
, Naoko Tomitani
, Tomoyuki Kabutoya
Narsingh Verma, Tzung Dau Wang, Ji Guang Wang
顯示 3 更多
顯示較少
*
此作品的通信作者
醫學系內科學科
研究成果
:
Review article
›
同行評審
35
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Diversity of and initiatives for hypertension management in Asia—Why we need the HOPE Asia Network」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Anticipation Medicine
11%
Asia
100%
Asian Population
11%
Blood Pressure Variability
22%
Cardiovascular Complications
11%
Cardiovascular Events
22%
Cardiovascular Outcomes
100%
Cardiovascular Risk
22%
Control Practices
11%
Early Morning
11%
Home Blood Pressure Monitoring
44%
Hypertension
100%
Hypertension Management
100%
Hypertension Prevalence
22%
Information Communication Technology
11%
Information Sharing
11%
Management Practices
11%
Masked Hypertension
33%
Monitoring System
11%
Morning Blood Pressure Surge
11%
Nocturnal Blood Pressure
11%
Nocturnal Hypertension
11%
Patients with Hypertension
11%
Population Aging
11%
Specific Features
22%
Technology-based
11%
Western Countries
11%
White-coat Hypertension
22%
Medicine and Dentistry
Anticipation
25%
Blood Pressure
50%
Blood Pressure Monitoring
100%
Blood Pressure Variability
50%
Cardiovascular Disease
25%
Cardiovascular Risk
50%
Cardiovascular System
50%
Hypertension
100%
Masked Hypertension
75%
Medicine
25%
Patient with Hypertension
25%
Prevalence
50%
White Coat Hypertension
50%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
33%
Cardiovascular Risk
66%
Hypertension
100%
Masked Hypertension
100%
Prevalence
66%
White Coat Hypertension
66%
Biochemistry, Genetics and Molecular Biology
Anticipation
16%
Blood Pressure
100%
Blood Pressure Variability
33%
Prevalence
33%